Sector: Pharmaceutical Preparations Region: France

: | Euronext Paris: ALEHT

Similar to: Ipsen SA, Pernix Therapeutics Holdings, Inc., BioGaia AB

Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.

News & Analysis

You may also be interested in: